Isthmus Partners, LLC Pfizer Inc Transaction History

Isthmus Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $163,280 - $209,747	-4,160 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $149,385 - $169,228	4,160 New	4,160 $163,000
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $59,628 - $67,983	-1,550 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $29,299 - $35,538	850 Added 121.43%	1,550 $68,000
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $24,538 - $28,468	-769 Reduced 52.35%	700 $25,000
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $45,539 - $50,166	1,469	1,469 $52,000

3,261

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Isthmus Partners, LLC with notifications on news.